Activation of the arylhydrocarbon receptor causes immunosuppression primarily by modulating dendritic cells

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 435-444

  Bruhs, Anika ^a   Haarmann Stemmann, Thomas ^b   Frauenstein, Katrin ^b   Krutmann, Jean ^b   Schwarz, Thomas ^a   Schwarz, Agatha ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 NONYLPHENOL; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; HAPTEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; CYTOKINE; NONYLPHENOL; PHENOL DERIVATIVE; VTCN1 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DNA DAMAGE; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; RADIATION RESPONSE; SECRETION (PROCESS); ULTRAVIOLET RADIATION;

ANIMALS; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; PHENOLS; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES, REGULATORY; ULTRAVIOLET RAYS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84922385685     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.419     Document Type: Article

References (40)

1. Abel J, Haarmann-Stemmann T (2010) An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem 391:1235-48
2. Beissert S, Schwarz A, Schwarz T (2006) Regulatory T cells. J Invest Dermatol 126:15-24
3. Bonefeld-Jørgensen EC, Long M, Hofmeister MV et al. (2007) Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 115(Suppl 1):69-76
4. Daidoji T, Inoue H, Kato S et al. (2003) Glucuronidation and excretion of nonylphenol in perfused rat liver. Drug Metab Dispos 31:993-8
5. Fritsche E, Schafer C, Calles C et al. (2007) Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 104:8851-6
6. Ghiringhelli F, Menard C, Terme M et al. (2005a) CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202:1075-85
7. Ghiringhelli F, Puig PE, Roux S et al. (2005b) Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 202:919-29
8. Green T, Swain C, Van Miller JP et al. (2003) Absorption, bioavailability, and metabolism of para-nonylphenol in the rat. Regul Toxicol Pharmacol 38:43-51
9. Grisolia CK, Bilich MR, Formigli LM (2004) A comparative toxicologic and genotoxic study of the herbicide arsenal, its active ingredient imazapyr, and the surfactant nonylphenol ethoxylate. Ecotoxicol Environ Saf 59:123-6
10. Harden JL, Egilmez NK (2012) Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest 41:738-64
11. Harréus UA, Wallner BC, Kastenbauer ER et al. (2002) Genotoxicity andcytotoxicity of 4-nonylphenol ethoxylate on lymphocytes as assessed by the COMET assay. Int J Environ Anal Chem 82:395-401
12. Jin GB, Moore AJ, Head JL et al. (2010) Aryl hydrocarbon receptor activation reduces dendritic cell function during influenza virus infection. Toxicol Sci 116:514-22
13. Jung K, Choi I (2013) Emerging co-signaling networks in t cell immune regulation. Immune Netw 13:184-93
14. Kretschmer K, Apostolou I, Hawiger D et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219-27
15. Kryczek I, Wei S, Zou L et al. (2006) Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177:40-4
16. Kulhankova K, Rouse T, Nasr ME et al. (2012) Dendritic cells control CD4+ CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2. PLoS One 7:e43609
17. Kushwah R, Hu J (2011) Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1:20
18. Lahl K, Loddenkemper C, Drouin C et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:57-63
19. Lan YY, Wang Z, Raimondi G et al. (2006) "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 177:5868-77
20. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-8
21. Mahnke K, Ring S, Johnson TS et al. (2007) Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 37:2117-26
22. McBride JM, Jung T, de Vries JE et al. (2002) IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol 215:162-72
23. Navid F, Bruhs A, Schuller W et al. (2013) The aryl hydrocarbon receptor is involved in UVR-induced immunosuppression. J Invest Dermatol 133:2763-70
24. Nguyen NT, Kimura A, Nakahama T et al. (2010) Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 107:19961-6
25. Nindl I, Rosl F (2009) Molecular pathogenesis of squamous cell carcinoma. Cancer Treat Res 146:205-11
26. Quintana FJ, Murugaiyan G, Farez MF et al. (2010) An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 107:20768-73
27. Ramsdell F, Ziegler SF (2014) FOXP3 and scurfy: how it all began. Nat Rev Immunol 14:343-9
28. Schmidt JV, Su GH, Reddy JK et al. (1996) Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93:6731-6
29. Schwarz A, Maeda A, Kernebeck K et al. (2005) Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 201:173-9
30. Schwarz A, Schwarz T (2010) UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype. J Invest Dermatol 130:1914-21
31. Schwarz T, Beissert S (2013) Milestones in photoimmunology. J Invest Dermatol 133:E7-10
32. Steinbrink K, Wolfl M, Jonuleit H et al. (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772-80
33. Tayama S, Nakagawa Y, Tayama K (2008) Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. Mutat Res 649:114-25
34. Tigges J, Weighardt H, Wolff S et al. (2013) Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. J Invest Dermatol 133:87-96
35. Turka LA, Walsh PT (2008) IL-2 signaling and CD4+CD25+Foxp3+ regulatory T cells. Front Biosci 13:1440-6
36. Vorderstrasse BA, Dearstyne EA, Kerkvliet NI (2003) Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells. Toxicol Sci 72:103-12
37. Watanabe H, Suzuki A, Goto M et al. (2004) Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. J Mol Endocrinol 33:243-52
38. Wincent E, Bengtsson J, Mohammadi Bardbori A et al. (2012) Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 109:4479-84
39. Zelante T, Fric J, Wong AY et al. (2012) Interleukin-2 production by dendritic cells and its immuno-regulatory functions. Front Immunol 3:161
40. Zhai S, Dai R, Friedman FK et al. (1998) Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab Dispos 26:989-92